Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
AI shopping assistants disrupt the e-commerce landscape! Bernstein: Platforms like Amazon (AMZN.US) and Uber (UBER.US) temporarily refusing integration may be a wise move

AI shopping assistants disrupt the e-commerce landscape! Bernstein: Platforms like Amazon (AMZN.US) and Uber (UBER.US) temporarily refusing integration may be a wise move

智通财经智通财经2026/10/23 15:26
Show original
As artificial intelligence (AI) agents gradually acquire the ability to autonomously search, shop, and complete transactions, traditional internet platforms are facing an important choice: should they proactively embrace third-party AI shopping assistants, or restrict their access to protect their own user relationships and business models? In its latest research report released on October 23, Bernstein pointed out that for internet platforms with significant market share, such as Amazon (AMZN.US), DoorDash (DASH.US), and Uber (UBER.US), refusing or limiting third-party AI agent access at this stage could be a completely reasonable business strategy.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Amgen (AMGN.US) and AstraZeneca (AZN.US) combination therapy extends small cell lung cancer survival by eight months, reduces risk of death by 58%

Researchers combined Amgen's Imdelltra with AstraZeneca's Imfinzi and found that for patients with aggressive lung cancer whose tumors had already spread, this combination extended survival by about eight months compared to Imfinzi monotherapy. Small cell lung cancer is one of the cancer types with the worst prognosis.

智通财经•2026/10/25 02:56
Amgen (AMGN.US) and AstraZeneca (AZN.US) combination therapy extends small cell lung cancer survival by eight months, reduces risk of death by 58%